Patel Mahesh V. 4
4 · Lipocine Inc. · Filed Jan 4, 2021
Insider Transaction Report
Form 4
Lipocine Inc.LPCN
Patel Mahesh V.
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-01-04$1.43/sh+275,000$393,250→ 275,000 totalExercise: $1.43From: 2022-01-04Exp: 2031-01-04→ Common Stock (275,000 underlying)
Footnotes (1)
- [F1]Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of January 4, 2022, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorata basis over the following two years.